Improving Jail Response to the Overdose Crisis: A Hybrid Trial of Jail ECHO to Improve MOUD Implementation and Public Health Outcomes (J-ECHO OPS)
4 de agosto de 2026 actualizado por: Rosemarie Martin, University of Massachusetts, Worcester
This project tests a training strategy to help rural jails start or increase their use of medications to treat opioid use disorder (MOUD - methadone, buprenorphine, naltrexone).
Staff from participating jails will attend a series of training sessions, called Project ECHO, that include online learning sessions with skilled experts, case-based discussions (real-world examples), and peer-to-peer learning opportunities.
Project ECHO is well-studied in healthcare settings but has rarely been used in correctional systems.
Staff from 40 rural jails and local treatment programs will participate in 6 months of core sessions (all participants attend the same sessions), followed by 12 months of continuing sessions (where content is tailored to participants' needs).
Staff will complete surveys about their knowledge and experience, and jails will provide data about their services.
Researchers will measure changes in MOUD services offered by the jails over time, as well as the impact these changes have on staff's work environment.
If Project ECHO helps expand MOUD services, it will offer a blueprint for expanding these life-saving services in other jails nationwide.
Descripción general del estudio
Estado
Aún no reclutando
Condiciones
Intervención / Tratamiento
Tipo de estudio
Intervencionista
Inscripción (Estimado)
100
Fase
- No aplica
Contactos y Ubicaciones
Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.
Estudio Contacto
- Nombre: JCOIN ECHO Coordinator
- Número de teléfono: 508-856-3515
- Correo electrónico: jcoinecho@umassmed.edu
Ubicaciones de estudio
-
-
Massachusetts
-
Worcester, Massachusetts, Estados Unidos, 01655
- UMass Chan Medical School
-
Investigador principal:
- Rosemarie Martin, PhD
-
Contacto:
- JCOIN ECHO Coordinator
- Número de teléfono: 508-856-3515
- Correo electrónico: jcoinecho@umassmed.edu
-
-
Criterios de participación
Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.
Criterio de elegibilidad
Edades elegibles para estudiar
- Adulto
- Adulto Mayor
Acepta Voluntarios Saludables
Sí
Descripción
Inclusion Criteria:
- Administrative, security, or healthcare staff in participating jails
- Employed at the facility a minimum of 3 months
Exclusion Criteria:
- Ongoing or recent participation in similar organizational improvement project
- Inability to read or understand English or Spanish
Plan de estudios
Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Investigación de servicios de salud
- Asignación: N / A
- Modelo Intervencionista: Asignación de un solo grupo
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: ECHO
Subjects participate in a series of facilitated ECHO learning sessions
|
Virtual learning sessions, case-based discussions, and peer-to-peer learning
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Increase in MOUD prescriptions (administrative data)
Periodo de tiempo: From baseline through the end of sustainment phase (18 months)
|
Administrative data tracking the number of MOUD prescriptions will be used to assess whether the jail has increased its use of MOUD to treat opioid use disorder relative to baseline.
|
From baseline through the end of sustainment phase (18 months)
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Organizational climate - Burnout (BAT-4)
Periodo de tiempo: From baseline to end of sustainment period (18 months)
|
Staff surveys measure Burnout via the 4-item Burnout Assessment Tool (BAT-4).
Items are scored from 1 (never) to 5 (always), and the mean is calculated (higher scores = greater burnout).
Change relative to baseline indicates impact of the intervention on this feature of organizational climate.
|
From baseline to end of sustainment period (18 months)
|
|
Organizational climate - Stress (TCU SOF subscale)
Periodo de tiempo: From baseline through end of sustainment period (18 months)
|
Staff surveys measure Stress via a validated 4-item subscale of the TCU Survey of Organizational Functioning.
Items are scored from 1 (disagree) to 5 (agree), and the mean is calculated (higher scores = greater perceived stress).
Change relative to baseline indicates impact of the intervention on this feature of organizational climate.
|
From baseline through end of sustainment period (18 months)
|
|
Organizational climate - Job Satisfaction (TCU SOF subscale)
Periodo de tiempo: From baseline through end of sustainment period (18 months)
|
Staff surveys measure job satisfaction using a 6-item validated subscale from the TCU Survey of Organizational Functioning.
Items are scored from 1 (strongly disagree) to 5 (strongly agree), and the mean is calculated (higher scores = greater job satisfaction).
Change relative to baseline indicates impact of the intervention on this feature of organizational climate.
|
From baseline through end of sustainment period (18 months)
|
|
Impact on Staff Knowledge: Opinions About MAT Questionnaire
Periodo de tiempo: From baseline through end of sustainment period (18 months)
|
Staff surveys include this 12-item scale, measuring familiarity, receipt of training, and perceived effectiveness of 4 formulations of medications for opioid use disorder.
Each item is rated on a 1-5 scale, with higher scores reflecting stronger endorsement.
Overall improvements in any of the 3 domains relative to baseline will indicate the intervention had a positive impact on staff knowledge about MOUD.
|
From baseline through end of sustainment period (18 months)
|
|
Disciplinary infractions (administrative data)
Periodo de tiempo: From baseline through end of sustainment phase (18 months)
|
Administrative data on the number and type of disciplinary infractions in past 6 months will assess the impact of MOUD service expansion on jail operations.
Infractions are recorded as violent infractions; non-violent infractions; and instances of MOUD diversion.
|
From baseline through end of sustainment phase (18 months)
|
|
Improvement on Opioid Services Cascade (BJS survey module)
Periodo de tiempo: From baseline through end of sustainment period (18 months)
|
The BJS survey of opioid use disorder screening and treatment (supplement to the 2019 Annual Survey of Jails) measures service delivery (yes/no) using 12 items across 6 domains.
An overall score is calculated by summing these responses, with higher scores relative to baseline indicating greater improvements in opioid treatment service delivery.
|
From baseline through end of sustainment period (18 months)
|
Colaboradores e Investigadores
Aquí es donde encontrará personas y organizaciones involucradas en este estudio.
Patrocinador
Colaboradores
Fechas de registro del estudio
Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.
Fechas importantes del estudio
Inicio del estudio (Estimado)
1 de septiembre de 2026
Finalización primaria (Estimado)
28 de febrero de 2030
Finalización del estudio (Estimado)
31 de mayo de 2030
Fechas de registro del estudio
Enviado por primera vez
16 de mayo de 2026
Primero enviado que cumplió con los criterios de control de calidad
5 de junio de 2026
Publicado por primera vez (Actual)
10 de junio de 2026
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
7 de agosto de 2026
Última actualización enviada que cumplió con los criterios de control de calidad
4 de agosto de 2026
Última verificación
1 de agosto de 2026
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- STUDY00002674
- RM1DA064507 (Subvención/contrato del NIH de EE. UU.)
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
SÍ
Descripción del plan IPD
Deidentified data from responses to staff surveys
Marco de tiempo para compartir IPD
Analytic files upon publication or no later than end of study (May 2030), indefinitely via public archives
Criterios de acceso compartido de IPD
Data will be shared via NIH-approved public data repository (likely ICPSR).
Registered users who consent to terms of data use agreement will be able to access deidentified data from staff surveys via download or within secure data enclave.
Tipo de información de apoyo para compartir IPD
- PROTOCOLO DE ESTUDIO
- CIF
- CÓDIGO_ANALÍTICO
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
No
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
No
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .